Carolyn Edwards

Carolyn Edwards

Company: Achilles Therapeutics

Job title: Director, Research Programs


Panel Discussion: Addressing the Key Challenges for Potency Assay Strategies for TIL Candidates 1:30 pm

• Discussing tumor specific vs. tumor-antigen specific assays and ideal tumor target material • Addressing the need for robust, reliable and reproducible assays for TIL therapies • TIL is a complex, patient-specific therapy, including product variability against unknown antigen specificityRead more

day: Day Two

Strategies for Developing a Potency Assay for a Clonal Neoantigen-Reactive Cell Therapy Product 12:30 pm

• Showcasing options for measuring potency effectively • Discussing data generation in Phase I trials • Transition from early stage to late-stage development for potency assays • Supporting characterization and development by designing phase appropriate potency assayRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.